Maria Pashayan Shares: Prognostic Implication of CYP2C19 Genotype
Maria Pashayan, Pharmacogenomics consultant at Center of Medical Genetics, posted on LinkedIn:
“In this large-scale, real-world analysis of DES-treated patients receiving clopidogrel-based dual antiplatelet therapy, high clinical risk (CHADS-P2A2RC ≥ 4 or TRS 2°P ≥ 3) was associated with worse clinical outcomes compared with low clinical risk.
Among clopidogrel-treated patients, carriage of the CYP2C19 LoF allele was linked to increased CV risk, particularly in those at high clinical risk. In low-risk patients, the prognostic relevance of the LoF allele carriage was mainly observed in those presenting with ACS.
Precision antiplatelet therapy works best when genetics + clinical risk + presentation (ACS vs CCS) are considered together—moving us closer to practical, evidence-based PGx implementation at the bedside.”
Title: Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent Implantation
Authors: Hyun Woong Park, Jae-Hwan Lee, Jin-Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong-Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin-Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo-Soo Kim, Moo Hyun Kim, Do-Sun Lim, Eun-Seok Shin, Paul A. Gurbel, Young-Hoon Jeong
Discover the latest in Hemostasis Today.
-
Apr 8, 2026, 16:25Xiaoying Chen: Teleneurological Ward As A Practical Way to Support High-Quality Stroke Care Beyond Major Centres
-
Apr 8, 2026, 16:24Ney Carter Borges: Endocrine Drivers of Resistant Hypertension – Insights from the MOMENTUM Trial at ACC 26
-
Apr 8, 2026, 16:21Jonathan Gelber: Exploring Papaya Extract as an Option to Elevate Platelet Numbers Before PRP
-
Apr 8, 2026, 16:21Marilena Vrana: Take Our New Global Survey on Patient Experiences with Plasma-Derived Medicines
-
Apr 8, 2026, 16:19Jaideep Patel: Are We Underestimating Heart Disease Risk in South Asians?
-
Apr 8, 2026, 16:16Hans Middelhoven: HARMONICS – Improving Stroke Care Outcomes in Spain and Portugal
-
Apr 8, 2026, 16:16Tiffany Hall: HerCare – the Ultimate ‘BOGO’ in Maternal Health
-
Apr 8, 2026, 16:14Haroun Gajraj: UGFS as a Minimally Invasive and Safe Option for Superficial Venous Thrombosis
-
Apr 8, 2026, 16:13Lama Samia: Biochemical Cascade of Myocardial Infarction